Dr. Shuyun Dong developed an new vaccine carrier that facilitated the direct loading of CTL epitopes onto MHC-I complexes on dendritic cell surface and enhanced the epitope-induced responses. This project is NIH-funded.
Peng Zhao engineered a recombinant nanoparticle that presented anti-programmed death-1 (PD-1) antibody in a multivalent fashion, which opened a new avenue to deliver and potentiate PD-1 antibody, an important cancer immunotherapeutic.
On The Media
Dr. Mingnan Chen and Peng Zhao shared their passion, accomplishments, and future plans of using vaccines and iTEP vaccine carriers to fight cancer on The Scope, the University of Utah Health Sciences Radio.
Chen Lab, Department of Pharmaceutics & Pharmaceutical Chemistry, University of Utah
30 South 2000 East, Salt Lake City, Utah 84112 USA
UNIVERSITY OF UTAH Department of Pharmaceutics
COLLEGE PHARMACY and Pharmaceutical Chemistry